Anti-Toxins

Neutralizing ricin

AntoXa is using the vivoXPRESS® system to produce an innovator antibody (PhD9) being studied by Defence Research and Development Canada (DRDC) as an antidote to ricin exposure.

Anti-nerve agents

AntoXa awarded federal government contract for anti-nerve agent enzyme

GUELPH, Ontario, Canada, March 20, 2019 — AntoXa Corporation has been awarded a contract with the Government of Canada to continue work on production of plant-made butyrylcholinesterase (BuChE), a protein that provides protection against toxic nerve agents such as sarin and soman. The one-year contract, worth up to $329,395, with a possible extension for two more… Read more >

Antivirals

Antibodies for Ebola

Antibodies produced using the vivoXPRESS® biopharmaceutical manufacturing system have been shown to neutralize the Sudan strain of Ebola as well as antibodies produced using other systems.

News